• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    NEWMAN DONALD P

    (Last) (First) (Middle)
    300 KIMBALL DRIVE, SUITE 101

    (Street)
    PARSIPPANY NJ 07054

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    AdvanSix Inc. [ ASIX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    11/18/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.01 11/18/2024 P 5,030 A $29.64(1) 5,030 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $29.56 to $29.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
    Remarks:
    /s/ Achilles B. Kintiroglou for Donald P. Newman 11/19/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ASIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    SEC Filings

    See more
    • SEC Form DEFA14A filed by AdvanSix Inc.

      DEFA14A - AdvanSix Inc. (0001673985) (Filer)

      5/16/25 5:16:37 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by AdvanSix Inc.

      10-Q - AdvanSix Inc. (0001673985) (Filer)

      5/2/25 4:42:48 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - AdvanSix Inc. (0001673985) (Filer)

      5/2/25 6:31:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/13/24 4:55:58 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/9/24 9:58:57 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by AdvanSix Inc.

      SC 13G - AdvanSix Inc. (0001673985) (Subject)

      2/7/24 8:39:58 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      11/19/24 4:20:20 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    See more
    • AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

      9/12/24 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Donald P. Newman to Board of Directors

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

      8/19/24 4:30:00 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Farha Aslam to Board of Directors

      AdvanSix (NYSE:ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy and food processing industries. Ms. Aslam will serve on the Audit Committee and the Compensation and Leadership Development Committee of the Board of Directors. AdvanSix's Board now consists of 10 members, including nine independent directors. "We are very excited to welcome Farha to the AdvanSix Board and leverage her agribusiness experience and financial expertise to progress our corporate strategic prioritie

      12/14/21 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdvanSix upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

      5/19/25 8:45:52 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

      4/7/25 8:48:39 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • Piper Sandler initiated coverage on AdvanSix with a new price target

      Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

      11/12/21 4:57:29 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, General Counsel Kintiroglou Achilles B. sold $13,504 worth of shares (571 units at $23.65), decreasing direct ownership by 2% to 32,555 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      6/4/25 5:19:48 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SVP, General Counsel Kintiroglou Achilles B. sold $69,078 worth of shares (3,237 units at $21.34), decreasing direct ownership by 9% to 33,126 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      5/5/25 4:32:02 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Williams Patrick was granted 579 shares, increasing direct ownership by 2% to 28,545 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      4/2/25 5:43:52 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Financials

    Live finance-specific insights

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials